Syngene International is currently trading at Rs. 503.50, up by 8.80 points or 1.78% from its previous closing of Rs. 494.70 on the BSE.
The scrip opened at Rs. 495.00 and has touched a high and low of Rs. 504.45 and Rs. 495.00 respectively. So far 9,584 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 663.30 on 09-Dec-2017 and a 52 week low of Rs. 430.00 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 508.00 and Rs. 491.75 respectively. The current market cap of the company is Rs. 10,070.00 crore.
The promoters holding in the company stood at 74.50%, while public and others held 23.37% and 2.12% respectively.
Syngene International has expanded its ongoing collaboration with Bristol-Myers Squibb. The next phase of the partnership will see the addition of a new facility to support future Bristol-Myers Squibb research and development operations, an expansion of the team and the extension of the existing agreement through 2026. The expansion will enable the two companies to undertake a greater range of scientific research and development for pharmaceuticals across a broader range of activities.
As part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 square feet of laboratory and office space for Bristol-Myers Squibb. This facility will house an additional team of 75 Syngene scientists who will work exclusively in support of Bristol-Myers Squibb.
Syngene International is India’s largest Contract Research Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
Company Name | CMP |
---|---|
Syngene Internation. | 683.25 |
Sagility India | 42.29 |
AGS Transact Tech | 11.46 |
Just Dial | 837.00 |
Krystal Integrated | 428.70 |
View more.. |